Elamipretide

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Elamipretide (SS-31、MTP-131、Bendavia) 是一种新型细胞渗透性抗氧化剂四肽 (D-Arg-二甲基Tyr-Lys-Phe-NH2)，靶向线粒体内膜并防止神经元细胞和其他细胞类型的氧化损伤。 3期临床

Elamipretide (SS-31, MTP-131, Bendavia) is a novel cell-permeable antioxidant tetrapeptide (D-Arg-dimethylTyr-Lys-Phe-NH2) that targets inner mitochondrial membrane and prevents oxidative damage of neuronal cells and other cell types; prevents mitochondrial depolarization, reduces islet cell apoptosis, increases islet cell yield, and improves posttransplantation function.Other Indication Phase 3 Clinical.

——

——

SS-31 | MTP-131 | Bendavia

Others

Other Targets

Other Targets

Other Indications

Other Disease

736992-21-5

639.802

C32H49N9O5

>98% (HPLC)

In Vitro:?DMSO : ≥ 29 mg/mL (45.33 mM)

O=C(N)[C@H](CC1=CC=CC=C1)NC([C@H](CCCCN)NC([C@H](CC2=C(C)C=C(O)C=C2C)NC([C@@H](CCCNC(N)=N)N)=O)=O)=O

(S)-6-amino-N-((S)-1-amino-1-oxo-3-phenylpropan-2-yl)-2-((S)-2-((R)-2-amino-5-guanidinopentanamido)-3-(4-hydroxy-2,6-dimethylphenyl)propanamido)hexanamide

(-20℃)

With Ice Pack

≥ 2 years